Medical Cannabis: UK

Parliamentary Reports

• Cannabis: the scientific and medical evidence
  UK House of Lords Select Committee on Science and Technology report on cannabis for medical purposes. It is a comprehensive report and includes recommendations. November 1998. (Science and Technology - Ninth Report)
• Therapeutic Uses of Cannabis
  A report from the UK House of Lords Select Committee on Science and Technology addressing issues raised in the earlier inquiry 'Cannabis: The Scientific and Medical Evidence'. March 2001. (Science and Technology - Second Report)
• The Government’s Drugs policy – Is it working?
  A report from the UK House of Commons examining the UK Government’s policies on illicit drugs including cannabis. May 2002 (Home Affairs _ Third Report)

GW Pharmaceuticals
GW is a pharmaceutical company developing a portfolio of prescription medicines derived from cannabis to meet patient needs in a wide range of therapeutic indications.

• Product Monograph: Sativex. 13 April 2005
• GW Announces Positive Preliminary Results with its Cannabis-based Medicine (Sativex®) in Phase III Cancer Pain Trial. 19 January 2005
• Media Report: GW receives Qualifying Notice for approval in Canada for Sativex®. 21 December 2004
• Media Report: Regulatory Update - UK and Canada. 3 December 2004
• Interim Results For The Six Months Ended 31 March 2004

CAMS - Cannabinoids in Multiple Sclerosis Trial

Multiple Sclerosis Trust

• Cannabis spay not recommended for licence
• Media Report: MS Trust deeply disappointed that people with MS are no nearer to having access to medicinal cannabis on the NHS. 3 December 2004

Regulatory Bodies

Medicines and Healthcare Products Regulatory Agency (MHRA)
The executive agency of the UK Department of Health protecting and promoting public health and patient safety by ensuring that medicines, healthcare products and medical equipment meet appropriate standards of safety, quality, performance and effectiveness, and are used safely.

Committee on Safety of Medicines (CSM)
The Committee advises the UK Licensing Authority to ensure that medicines meet the standards of quality, efficacy and safety the public and health professions would expect.

Media Reports

• 20 January 2005. The UK Guardian. Trials of cannabis pain relief raise hope for terminally ill
• McGill University. Doctor suggested cannabis for pain relief, says one in six medicinal cannabis users in the UK. 16 March 2005